International Patent: ANTIBODIES OR ANTIGEN-BINDING FRAGMENTS THEREOF CAPABLE OF BINDING TO TL1A AND USES THEREOF

GENEVA, Sept. 18 -- GENERATE BIOMEDICINES, INC. filed a patent application (US2026/018161) for “ANTIBODIES OR ANTIGEN-BINDING FRAGMENTS THEREOF CAPABLE OF BINDING TO TL1A AND USES THEREOF”. With publication no. WO/2026/188186, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....